Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease

被引：16

作者：

Spiegel, Joerg ^{[1
]}

机构：

[1] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany

来源：

PARKINSONS DISEASE | 2010年 / 2010卷

关键词：

CARDIAC SYMPATHETIC DENERVATION; I-123-MIBG SCINTIGRAPHY; LEWY BODIES; DIFFERENTIAL-DIAGNOSIS; CLINICAL-DIAGNOSIS; METAIODOBENZYLGUANIDINE; DEGENERATION; DYSFUNCTION; PHEOCHROMOCYTOMA; ACCURACY;

D O I：

10.4061/2010/295346

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson's disease (PD). Numerous studies address the pathophysiological impact of myocardial MIBG scintigraphy: the myocardial MIBG uptake correlates with the clinical phenotype of PD; the background of this phenomenon is unclear. Furthermore MIBG scintigraphy enables to study the extracranial Lewy body type-degeneration. In combination with cerebral dopamine transporter imaging, MIBG scintigraphy allows to correlate cerebral and extracranial Lewy body type-degeneration in PD.

引用

页数：6

共 50 条

[31] Significance of myocardial 131I-meta-iodobenzylguanidine (MIBG) scintigraphy in the diagnosis of Parkinson's disease (preliminary report)
Petrovic, R.
Samardzic, T.
Tezak, S.
Telarovic, S.
Klepac, N.
Relja, M.
Poropat, M.
Dodig, D.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S307 - S308
[32] Evaluation of DAT-SPECT and 123I-MIBG myocardial scintigraphy in the diagnosis and staging of Parkinson's disease
Shigekiyo, T.
Unoda, K.
Ishida, S.
Nakajima, H.
Kimura, H.
Arawaka, S.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 956 - 956
[33] The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson's disease
Ebina, J.
Sekiguchi, T.
Takahashi, M.
Inaba, A.
Orimo, S.
MOVEMENT DISORDERS, 2016, 31 : S429 - S429
[34] Significance of123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: It can be a specific marker for Lewy body disease
Junichi Taki
Mitsuhiro Yoshita
Masahito Yamada
Norihisa Tonami
Annals of Nuclear Medicine, 2004, 18 : 453 - 461
[35] Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders:: It can be a specific marker for Lewy body disease
Taki, J
Yoshita, M
Yamada, M
Tonami, N
ANNALS OF NUCLEAR MEDICINE, 2004, 18 (06) : 453 - 461
[36] Is 123I-MIBG cardiac scintigraphy a surrogate marker for Parkinson's disease?
Fukuyama, Hidenao
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) : 1 - 2
[37] Is 123I-MIBG cardiac scintigraphy a surrogate marker for Parkinson’s disease?
Hidenao Fukuyama
European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1 - 2
[38] MIBG scintigraphy in the diagnostic of pheochromocytoma
Farahati, J
Reiners, C
ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (06): : 443 - 446
[39] DAT SPECT and MIBG myocardial scintigraphy imaging profiles and clinical stages in Parkinson's disease and dementia with Lewy Bodies.
Kujuro, Y.
Hattori, H.
Ohta, K.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 314 - 314
[40] THE DIAGNOSTIC UTILITY OF I-123 METAIODOBENZYLGUANIDINEE (MIBG) SCINTIGRAPHY IN DIFFERENTIATING PARKINSON'S DISEASE FROM OTHER FORMS OF PARKINSONISM
Sek, K.
Loh, N.
Kwan, K.
Vieira, B.
INTERNAL MEDICINE JOURNAL, 2012, 42 : 13 - 13

← 1 2 3 4 5 →